Compound ID | 597

JNJ-17155437

Class: Macrolide (15-membered macrolide, ketolide)

Spectrum of activity: Gram-positive
Description: Synthetic compound, derived from 15-methylerythromycin A
Institute where first reported: Johnson & Johnson Pharmaceutical
Year first mentioned: 2002
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: Likely to be due to the failure of Ketek (Telithromycin)- (LS)

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.